19.50p-1.25 (-6.02%)04 Jul 2022, 16:19
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Allergy Therapeutics PLC Market & Company News

01.07.2022 07:00AGYAllergy Therapeutics at EAACI Congress 2022Reach
26.05.2022 22:00UJO, STB, AGYTRADING UPDATES: DP Eurasia posts strong sales growth on Turkey demandAlliance
26.05.2022 07:00AGYNick Wykeman to step down as CFORNS
23.05.2022 07:00AGYAllergy Therapeutics at H.C. Wainwright ConferenceReach
25.04.2022 07:00AGYAllergy Therapeutics shares data at WAO-BSACIReach
08.03.2022 07:00AGYAllergy Therapeutics at Cowen Health ConferenceReach
07.03.2022 07:00AGYAllergy Therapeutics at Investor Meet CompanyReach
04.03.2022 20:53AGY, ONC, FARNTRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at DonegalAlliance
03.03.2022 19:32POW, AGY, TRACTRADING UPDATES: Avation loss narrows; Franchise Brands profit risesAlliance
03.03.2022 07:00AGYAllergy Therapeutics plc – Interim ResultsRNS
01.03.2022 07:00AGYAllergy Therapeutics shares positive new dataReach
24.02.2022 16:41AGYSecond Price Monitoring ExtnRNS
24.02.2022 16:36AGYPrice Monitoring ExtensionRNS
24.02.2022 14:06AGYSecond Price Monitoring ExtnRNS
24.02.2022 14:01AGYPrice Monitoring ExtensionRNS
02.02.2022 11:05AGYSecures new revolving credit facilityRNS
01.02.2022 14:16AGYTotal Voting RightsRNS
26.01.2022 07:00AGYFDA clearance of IND application for VLP PeanutRNS
24.01.2022 13:13AGYHolding(s) in CompanyRNS
13.01.2022 07:00AGYHalf Year Trading Update & Notice of ResultsRNS
05.01.2022 08:47AGYTotal Voting RightsRNS
25.11.2021 09:17AGYAllergy Therapeutics: Granting of AwardsRNS
23.11.2021 12:54AGYResult of AGMRNS
11.11.2021 07:00AGYDirector DealingsRNS
27.10.2021 07:00AGYCheryl MacDiarmid appointed to Board of DirectorsRNS
25.10.2021 09:00AGYPrice Monitoring ExtensionRNS
25.10.2021 07:00AGYAllergy announces positive G309 resultsRNS
14.10.2021 09:24AGYHolding(s) in CompanyRNS
07.10.2021 16:37AGYAnnual Report and AGM NotificationRNS
23.09.2021 07:00AGYPreliminary Results for Year ended 30 June 2021RNS
16.09.2021 07:00AGYImmunoBON voted Most Innovative Product of 2021Reach
13.09.2021 07:00AGYSecondary endpoints from VLP Peanut 001RNS
09.09.2021 07:00AGYAllergy to Present at H.C. Wainwright ConferenceReach
07.09.2021 07:00AGYAllergy to host KOL webinar on VLP PeanutReach
03.08.2021 07:00AGYSuccessful primary outcome of VLP Peanut 001RNS
02.08.2021 10:57AGYTotal Voting RightsRNS
14.07.2021 07:00AGYTrading update for the year ended 30 June 2021RNS
08.07.2021 07:00AGYAGY to present key scientific findings at EAACIReach
24.06.2021 07:00AGYTrading UpdateRNS
01.06.2021 15:36AGYTotal Voting RightsRNS
10.05.2021 14:06AGYSecond Price Monitoring ExtnRNS
10.05.2021 14:00AGYPrice Monitoring ExtensionRNS
06.05.2021 07:00AGYCompletion of treatment phase in G309 studyRNS
30.04.2021 17:47AGYTotal Voting RightsRNS
31.03.2021 08:29AGYVesting of Awards under Long Term Incentive PlanRNS
26.03.2021 16:39AGYPledge of SharesRNS
11.03.2021 12:13AGYPledge of SharesRNS
10.03.2021 16:40AGYSecond Price Monitoring ExtnRNS
10.03.2021 16:35AGYPrice Monitoring ExtensionRNS
10.03.2021 14:05AGYSecond Price Monitoring ExtnRNS
10.03.2021 14:00AGYPrice Monitoring ExtensionRNS
08.03.2021 07:00AGYAGY to Present at H.C. Wainwright ConferenceRNS
03.03.2021 07:00AGYInterim Results for six months ended 31 Dec 2020RNS
15.01.2021 07:00AGYBlock Listing Return and Total Voting RightsRNS
13.01.2021 07:00AGYHalf Year Trading Update 2021 & Notice of ResultsRNS
08.01.2021 16:41AGYSecond Price Monitoring ExtnRNS
08.01.2021 16:36AGYPrice Monitoring ExtensionRNS
05.01.2021 07:00AGYInitiation of peanut allergy biomarker studyRNS
Showing 1 to 58 of 58